Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Viking Therapeutics (VKTX) Other Non-Current Assets: 2014-2025

Historic Other Non-Current Assets for Viking Therapeutics (VKTX) over the last 9 years, with Sep 2025 value amounting to $46,000.

  • Viking Therapeutics' Other Non-Current Assets changed negligibly% to $46,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $46,000, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $46,000 for FY2024, which is 39.39% up from last year.
  • As of Q3 2025, Viking Therapeutics' Other Non-Current Assets stood at $46,000, which was down 0.00% from $46,000 recorded in Q2 2025.
  • In the past 5 years, Viking Therapeutics' Other Non-Current Assets registered a high of $46,000 during Q3 2024, and its lowest value of $33,000 during Q4 2021.
  • Over the past 3 years, Viking Therapeutics' median Other Non-Current Assets value was $33,000 (recorded in 2024), while the average stood at $38,909.
  • Data for Viking Therapeutics' Other Non-Current Assets shows a peak YoY surged of 39.39% (in 2024) over the last 5 years.
  • Viking Therapeutics' Other Non-Current Assets (Quarterly) stood at $33,000 in 2021, then remained steady at $33,000 in 2022, then remained steady at $33,000 in 2023, then soared by 39.39% to $46,000 in 2024, then remained steady at $46,000 in 2025.
  • Its Other Non-Current Assets was $46,000 in Q3 2025, compared to $46,000 in Q2 2025 and $46,000 in Q1 2025.